CLIRF yields 1000000.00% · PFE yields 6.13%● Live data
📍 CLIRF pulled ahead of the other in Year 1
Combined, CLIRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLIRF + PFE for your $10,000?
Clearford Water Systems Inc., a water management company, provides unified water infrastructure solutions in Canada, the United States, India, South America, and internationally. It operates in three segments: Waterworks, Water & Wastewater Infrastructure Delivery, and UV Pure Disinfection. The company offers Clearford One, a three-stage solution for wastewater servicing; ClearDigest, an on-site pre-treatment stage that removes solids at the source; ClearConvey, a network of small bore sewer pipes that carries liquids without any infiltration to an optimized facility for final treatment; and ClearRecover, a treatment facility. It also provides Clearford M-brane, a lifecycle solution for managed and decentralized water treatment; Clearford UV, which offers potable, wastewater, reuse, and rainwater disinfection systems; and Clearford Pay-for-Performance project financing program solutions. In addition, the company designs, manufactures, and sells ultraviolet purification systems using its patented Crossfire technology into the potable water, wastewater, reuse, and rainwater harvesting markets. Further, it provides water supply and wastewater treatment systems for small communities, as well as manufactures and supplies packaged treatment solutions, including containerized membrane plants for advanced water treatment. The company was formerly known as Clearford Industries Inc. and changed its name to Clearford Water Systems Inc. in June 2014. Clearford Water Systems Inc. is headquartered in Ottawa, Canada.
Full CLIRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.